Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04730609 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

StatusWithdrawn
PhasePhase 4
Started2021-09-21
View on ClinicalTrials.gov ↗

Amendment history

2026-09-19
Trial status changed: Recruiting → Withdrawn
Trial withdrawn: Unable to start study.
2025-09-05
Study Status, Oversight, References v7
Primary completion date2025-08→2026-08
Completion date2025-08→2026-08
2024-09-04
Study Status, Oversight, Contacts/Locations v6
Primary completion date2024-08→2025-08
Completion date2024-08→2025-08
2023-09-27
Study Status v5
Primary completion date2023-08→2024-08
Completion date2023-08→2024-08
2022-09-26
Study Status, Contacts/Locations v4
Primary completion date2023-02→2023-08
Completion date2023-02→2023-08
Study sitescontacts updated at 1 of 1 site
Show 3 earlier versions
2021-09-21
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-08→confirmed 2021-09-21
Study sitesdetails revised at 1 of 1 site
2021-07-13
Study Status v2
Start date2021-06→2021-08
2021-03-24
Study Status v1
Start date2021-02→2021-06
2021-01-28
Original filing
Mayo Clinic
1,015 trials monitored
See 115 trials at risk
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Trial Details
NCT Number NCT04730609
Lead Sponsor Mayo Clinic
Conditions Shivering, Dose Finding Study
Start Date 2021-09-21
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-18